MMIT - Managed Markets Insight & Technology

  • Home
  • MMIT - Managed Markets Insight & Technology

MMIT - Managed Markets Insight & Technology We leverage technology, research and industry experts to make sense of how and why specific pharmaceutical drugs are covered.

16/03/2026

More clarity. More context. More confidence.

Asembia 2026 is coming, and MMIT is bringing so much more than market access data. Catch us April 27–30 at Booth 1415 in Las Vegas.

Reserve your spot today: https://vist.ly/4u2sk

16/03/2026

As the year wraps up, it’s worth asking: Is your message breaking through or getting lost in the noise? https://vist.ly/4u2gr

MMIT’s Message Monitor gives you a “fly-on-the-wall” view into real conversations between payers, HCPs, and IDNs, so you can see exactly how your message resonates, where it stands against competitors, and what decision-makers really think. Now’s the time to fine-tune your story and strengthen your strategy before new coverage and formulary updates roll out.

Schedule a demo to gain insights into payer and IDN brand perception.

https://vist.ly/4uymk | Accurately identify patients and their HCPs, even for rare and hard-to-diagnose conditions. MMIT...
15/03/2026

https://vist.ly/4uymk | Accurately identify patients and their HCPs, even for rare and hard-to-diagnose conditions. MMIT’s HCP and Patient Targeting Solution is powered by NorstellaLinQ, the industry’s first fully integrated data asset. By combining structured and unstructured data, we help you pinpoint the right patients and the providers who treat them. Learn how precision targeting yields more effective results.

https://vist.ly/4ujfz | Get closer to the patient than ever before. MMIT, powered by NorstellaLinQ, delivers pharma’s fi...
11/03/2026

https://vist.ly/4ujfz | Get closer to the patient than ever before. MMIT, powered by NorstellaLinQ, delivers pharma’s first fully linked and integrated data asset. With unmatched access to open and closed claims, lab results, EMRs, and coverage data, we help you build smarter, faster market access strategies. Learn more at the link in this post.

11/03/2026

https://vist.ly/4uiek | The FTC says Optum Rx and Caremark are in talks to settle the same lawsuit that led Express Scripts to agree to end the practice of preferring more expensive drugs on formularies. Will other PBMs agree to similar reforms? Find out with MMIT’s industry‑leading payer panel.

To support your understanding of market shifts like these, MMIT’s Rapid Family is a suite of solutions designed to deliver timely, actionable insights. By leveraging our expert team and industry‑leading panel, you gain fast access to the answers you need to stay ahead of market changes. Learn more at the link in this post.

10/03/2026

Free-text plan names are like junk drawers. You can dig through them… but wouldn’t you rather know exactly what’s inside?

With MMIT’s BIN/PCN/Group mapping, you gain structure, clarity, and confidence in coverage insights.

Meet with MMIT to learn more. Because guessing isn’t a strategy. https://vist.ly/4ueei

09/03/2026

You can track what payers say.
You can monitor what prescribers do.
But do you see what happens in between?

Watch this video to see how MMIT connects data, AI‑powered insights, and human intelligence to help teams see the real picture in market access—and make more confident decisions.

👉 Turn data into clarity with MMIT: https://vist.ly/4ubis

https://vist.ly/4u82e | Employee Spotlight! Team lead and senior access advisor Jacquie Eckrote enjoys helping pharma he...
09/03/2026

https://vist.ly/4u82e | Employee Spotlight! Team lead and senior access advisor Jacquie Eckrote enjoys helping pharma help companies understand how payer policies impact their therapies.

07/03/2026

Is your message breaking through or getting lost in the noise? https://vist.ly/4u4bg

MMIT’s Message Monitor gives you a “fly-on-the-wall” view into real conversations between payers, HCPs, and IDNs, so you can see exactly how your message resonates, where it stands against competitors, and what decision-makers really think. Now’s the time to fine-tune your story and strengthen your strategy before new coverage and formulary updates roll out.

Schedule a demo to gain insights into payer and IDN brand perception.

Coverage shouldn’t feel like detective work. 🕵️By standardizing BIN/PCN/Group data with MMIT, teams can reduce guesswork...
06/03/2026

Coverage shouldn’t feel like detective work. 🕵️

By standardizing BIN/PCN/Group data with MMIT, teams can reduce guesswork and focus on what actually matters: patient access and informed decisions.

Clarity changes everything. Illuminate your path with MMIT today. https://vist.ly/4t248

04/03/2026

Unstructured data has become one of the most valuable assets for market access teams—and machine learning and natural language processing are the key to unlocking it. https://vist.ly/4tpi3

Discover six real examples of how organizations are using these technologies to inform targeting, improve access, and strengthen commercialization strategies.

Read now to uncover actionable insights

27/02/2026

Employee Spotlight! Meet Jacquie Eckrote, senior access advisor and competitive horseback rider. Jacquie helps clients interpret payer policy data and determine next steps to overcome any hurdles that impede patient access. https://vist.ly/4t54b

Address


Telephone

+12677513162

Website

Alerts

Be the first to know and let us send you an email when MMIT - Managed Markets Insight & Technology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to MMIT - Managed Markets Insight & Technology:

Shortcuts

  • Want your practice to be the top-listed Clinic?

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Solving the What and the Why of Market Access

We leverage technology, research and industry experts to make sense of how and why specific pharmaceutical drugs are covered. Physicians and pharmacies use our data and applications to understand what drugs are available to patients and how they are covered by health plans. Pharmaceutical manufacturers trust our data to understand how their drug and competitive drugs are covered, which helps forecast performance and tune strategy.